诺丁汉预后x (NPx):ER阳性HER2阴性乳腺癌的风险分层工具:一个验证研究
Ayat G Lashen1,2,3, Michael Toss1,4, Islam Miligy1,2
1Academic Unit for Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, UK.
Histopathology
|June 13, 2024
概括
诺丁汉预后指数 (NPx) 有效地预测了光线乳腺癌 (BC) 的结果. 这种使用瘤大小,等级和生物标志物的预后指数有助于指导早期BC患者的化疗决策.
科学领域:
- 在瘤学瘤学.
- 病理学 病理学 病理学
- 生物标志物 生物标志物
背景情况:
- 光线乳腺癌 (BC) 需要准确的预后工具来治疗分层.
- 目前的风险分层方法,如型DX复发率得分 (RS),被广泛使用.
- 需要有效的预后指数,包括易于获得的临床和病理数据.
研究的目的:
- 验证诺丁汉预后指数 (NPx) 作为光线早期乳腺癌 (BC) 的预后工具.
- 评估NPx与临床变量,患者结果和瘤型DX复发评分 (RS) 的相关性.
主要方法:
- 利用了两大群体的光线早期BC患者 (n=2864).
- 在切除样本上通过免疫组织化学评估孕激素受体 (PR) 和Ki67表达.
- 计算了NPx,并将其与临床数据,存活率和瘤型DX RS.相关联.
主要成果:
- 在NPx中,38%的患者被确定为高风险患者,明显与瘤的攻击性行为和更短的存活时间有关 (P<0.0001).
- NPx将温和的诺丁汉预后指数 (NPI) 风险组分为不同的预后子组.
- 在NPx和瘤型DXRS (P<0.0001) 之间发现了强烈的关联,中期RS患者的高风险NPx预测了远程转移.
结论:
- NPx是光早期BC的可靠预后指数.
- 在选定的BC患者中,NPx可能会指导辅助化疗建议.
相关概念视频
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
01:12Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...